ICWIX | VENAX | ICWIX / VENAX | |
Total Expense Ratio | 1.00 | 0.09 | 1,111% |
Annual Report Gross Expense Ratio | 1.10 | 0.09 | 1,222% |
Fund Existence | 9 years | 21 years | - |
Gain YTD | 10.002 | -0.881 | -1,135% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 100000 | 1% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 135M | 8.78B | 2% |
Annual Yield % from dividends | 1.32 | 3.19 | 41% |
Returns for 1 year | 15.23 | -5.20 | -293% |
Returns for 3 years | 32.24 | 11.08 | 291% |
Returns for 5 years | 150.98 | 133.80 | 113% |
Returns for 10 years | N/A | 23.92 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
NLSCX | 18.64 | 0.02 | +0.11% |
Neuberger Berman Long Short C | |||
MXGSX | 13.08 | -0.02 | -0.15% |
Empower Large Cap Growth Instl | |||
QMORX | 24.03 | -0.10 | -0.41% |
AQR Large Cap Momentum Style R6 | |||
CEIIX | 13.99 | -0.06 | -0.43% |
Manning & Napier Callodine Equity Inc I | |||
KSMVX | 9.43 | -0.07 | -0.74% |
Keeley Gabelli SMID Cap Value A |